Timing of anticoagulation therapy in ischemic stroke patients with atrial fibrillation / 国际脑血管病杂志
International Journal of Cerebrovascular Diseases
;
(12): 442-446, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-751577
ABSTRACT
Early anticoagulation with conventional anticoagulants (such as heparin, low-molecular- weight heparin or warfarin) has no benefit in preventing recurrence of stroke in ischemic stroke patients with atrial fibrillation. Non-vitamin K oral anticoagulants (NOACs) has the same or better anticoagulant effect and much lower incidence of intracranial hemorrhage than warfarin, and it works on the same day. Although it has been available for less than 10 years, it has a tendency to replace warfarin. This article reviews the research progress in the prevention of early recurrence with NOACs in ischemic stroke patients with atrial fibrillation.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
International Journal of Cerebrovascular Diseases
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS